Command Palette
Search for a command to run...
Jupiter Life Line
NSE: JLHLBSE: 543980HEALTHCAREHEALTHCARE FACILITIES
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Jupiter Life Line
Jupiter Life Line Hospitals is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and western India with total operational bed capacity of 1061 across three hospitals located in Thane, Pune and Indore under the Jupiter Brand. The group is constructing two new multispeciality hospitals in Dombivli, Thane (Maharashtra) and Bibvewadi, Pune (Maharashtra) with potential capacity of 500 beds each and It has also purchased land for setting up a new hospital in Mira Road, Thane (Maharashtra) with potential capacity of 300 beds. The group is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism.
Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002. Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,194 across three hospitals located in Thane, Pune and Indore under the "Jupiter' brand. The Company is constructing a new multi-speciality hospital in Dombivali, Maharashtra with potential capacity of 500 beds. The Company is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company follow a `patient first' ideology by creating the best infrastructure, technology and support to put the patient first and foremost and be futuristic and innovative in delivery of healthcare. It serve the healthcare needs of patients and hospitals equipped hospitals with over 30 specialties, including key specialties of organ transplant, oncology, orthopaedics, cardiology, paediatrics, neurology and neurosurgery as well as certain specialized quaternary services and precision-based treatments such as brachytherapy, radiotherapy, robotic knee replacement and robotic neuro rehabilitation. The Company commenced its business in December, 2002. It started operations at Thane hospital, Maharashtra in 2007. Later, it scaled operations by setting up a hospital in Pune in 2017. The Company carried out interstitial brachytherapy to treat cancer in Thane Hospital in 2018. In 2020, it acquired the Indore Hospital in Madhya Pradesh. In 2021, the Company carried out small bowel intestine transplant surgery at Thane Hospital and heart transplant surgery at Thane Hospital in 2022. In September 2023, Company made an IPO of 11,824,163 Equity Shares by raising funds aggregating to Rs 869 Crore comprising a Fresh Issue of 7,374,163 Equity Shares aggregating to Rs 542 Crore and an Offer for Sale of 4,450,000 Equity Shares aggregating to Rs 327 Crore. The Company added 22 beds in Pune and 78 beds in Indore, along with commissioning a new 11-bed ICU in FY 25. By deconstructing a 22-bed unit, it created room for two additional operating theatres, a second MRI machine, a second cath lab, expanded Daycare and Chemotherapy Suites, and a new OPD cluster.
Price Action • JLHL
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '16 |
|---|---|---|---|---|---|---|---|---|
Total Revenue | 1,176.07 | 1,088.14 | 940.26 | 800.62 | 661.03 | 465.12 | 464.83 | 252.81 |
Operating Expenses | 850.81 | 790.78 | 687.26 | 583.29 | 498.43 | 392.02 | 380.34 | 189.35 |
Operating Profit | 286 | 269.22 | 223.37 | 204.03 | 158.85 | 69.07 | 82.6 | 61.16 |
Operating Margin (%) | - | 24.74 | 23.76 | 25.48 | 24.03 | 14.85 | 17.77 | 24.19 |
Total Expenses | - | 841.79 | 736.44 | 639.61 | 555.32 | 447.58 | 431.94 | 207.76 |
EBITDA | - | 297.36 | 253 | 217.33 | 162.6 | 73.1 | 84.49 | 63.46 |
EBITDA Margin (%) | - | 27.33 | 26.91 | 27.14 | 24.6 | 15.72 | 18.18 | 25.1 |
Interest Expenses | 12.62 | 8.6 | 18.66 | 27.71 | 29.23 | 28.17 | 25.69 | 7.69 |
Depreciation | 57.36 | 42.41 | 30.52 | 28.61 | 27.66 | 27.38 | 25.91 | 10.72 |
Profit Before Tax (PBT) | 255.29 | 246.34 | 203.82 | 158.88 | 105.71 | 17.55 | 32.89 | 45.05 |
Tax Expenses | 63.64 | 61.64 | 51.87 | 51.67 | 21.04 | 0.96 | 3.26 | 13.97 |
PAT Before Extraordinary Items | - | 184.7 | 151.95 | 107.21 | 84.67 | 16.59 | 29.63 | 31.07 |
Net Profit | 191.65 | 184.7 | 151.95 | 107.21 | 84.67 | 16.59 | 29.63 | 31.07 |
Net Profit Margin (%) | - | 17.42 | 16.68 | 13.61 | 12.88 | 3.59 | 6.4 | 12.4 |
EPS (Adjusted) | - | 28.17 | 23.18 | 16.35 | 12.91 | 2.53 | 4.52 | 4.74 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '16 |
|---|---|---|---|---|---|---|---|---|
Book Value Per Share | - | 216.96 | 189.92 | 82.28 | 64.3 | 49.8 | 46.54 | 27.9 |
Return on Assets (ROA) % | - | 10.79 | 11.16 | 12.1 | 11.21 | 2.66 | 4.99 | 10.43 |
Return on Equity (ROE) % | - | 12.98 | 12.2 | 23.05 | 25.88 | 6.54 | 12.51 | 22.27 |
Return on Capital Employed (ROCE) % | - | 16.04 | 17.48 | 24.04 | 20.71 | 8.56 | 11.71 | 22.42 |
Profitability Ratios | - | - | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0.05 | 0 | 0.64 | 0.98 | 1.02 | 1.07 | 0.74 |
Featured Insight
No recent news available
Key People
A
Ankit Ajay Thakker
Executive Director,Chief Executive Officer
M
Mr. Harshad Purani
Chief Financial Officer,President(Administration),Head(Csr)
D
Dr. Shilpa Tatake
Chief Operating Officer
M
Mr. Anand Apte
Chief Business Officer,Investor Relations Officer
D
Dr. Rajendra Patankar
Chief Executive Officer(Hospital)
M
Mr. Neelesh Shinde
Chief Technical Officer,Head(Projects)
M
Mr. Pradip Acharya
Head(Corporate Relations)
M
Mrs. Manisha Shah
Group Chief Human Resources Officer
M
Mr. Sumit Goda
Corporate Head(Supply Chain.,Cpu.)
S
Suma Upparatti
Company Secretary,Compliance Officer
M
Mr. Sivasis Salilkumar Sen
Chief Financial Officer